26 May 2013
Keywords: biogen, 3rd-qtr, profit, falls, merger, costs, biotechnology
Article | 08 November 2004
US biotechnology giant Biogen Idec says its earnings for the third quarter of 2004 were down on merger-related charges but, after ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.